In the wake of the second wave of the COVID-19 pandemic, the company R launched a product named Coronil, claiming it to be the “first evidence-based medicine for COVID-19.
Kartavya Desk Staff
Q7. In the wake of the second wave of the COVID-19 pandemic, the company R launched a product named Coronil, claiming it to be the “first evidence-based medicine for COVID-19.” Advertising materials suggested the product was certified and endorsed by the World Health Organisation (WHO). However, WHO promptly clarified that it had not certified any natural medicine for curing coronavirus. Subsequently, the founder of R stirred controversy by releasing a viral video criticizing allopathic medicine as responsible for the deaths of thousands. In response, the Indian Medical Association (IMA) issued a legal notice demanding an apology and withdrawal of the statements made against allopathy. In an attempt to defend its position, R firm published advertisements in major newspapers across the country alleging, “Misconceptions Spread by Allopathy.” which projected modern medicine in a negative image and mentioned it as non-impactful. These claims blatantly contravened the Drugs and Magic Remedies (Objectionable Advertisements) Act, of 1954, which strictly prohibits misleading advertisements of medical products. (20 M)
• Identify the stakeholders in the case. What are the ethical issues involved in the case? How should companies balance commercial interests with the responsibility to provide accurate and truthful information in public health crises? [20M]
• Identify the stakeholders in the case.
• What are the ethical issues involved in the case?
• How should companies balance commercial interests with the responsibility to provide accurate and truthful information in public health crises? [20M]
Difficulty Level: Medium
Why the question: This case study tests ethical issues in corporate responsibility, misinformation, and public health integrity, requiring an analysis of stakeholder interests, ethical dilemmas, and responsible business conduct. Key Demand of the Question: The question demands the identification of stakeholders, analysis of ethical concerns in misleading health claims, and strategies for balancing commercial interests with ethical responsibilities in public health crises. Structure of the Answer: Introduction: A relevant quote or a general statement on corporate ethics and truthfulness in public health communication. Body: Stakeholders: List and briefly explain key stakeholders affected by the case. Ethical Issues: Discuss concerns such as misinformation, public trust, regulatory violations, and corporate responsibility. Balancing Commercial Interests and Ethics: Suggest measures like ethical advertising, regulatory compliance, corporate responsibility, and crisis communication. Conclusion: Reinforce the importance of ethical corporate behaviour, especially in health-related sectors, emphasizing trust, truthfulness, and public welfare.
Why the question: This case study tests ethical issues in corporate responsibility, misinformation, and public health integrity, requiring an analysis of stakeholder interests, ethical dilemmas, and responsible business conduct.
Key Demand of the Question: The question demands the identification of stakeholders, analysis of ethical concerns in misleading health claims, and strategies for balancing commercial interests with ethical responsibilities in public health crises.
Structure of the Answer:
Introduction: A relevant quote or a general statement on corporate ethics and truthfulness in public health communication.
• Stakeholders: List and briefly explain key stakeholders affected by the case.
• Ethical Issues: Discuss concerns such as misinformation, public trust, regulatory violations, and corporate responsibility.
• Balancing Commercial Interests and Ethics: Suggest measures like ethical advertising, regulatory compliance, corporate responsibility, and crisis communication.
Conclusion: Reinforce the importance of ethical corporate behaviour, especially in health-related sectors, emphasizing trust, truthfulness, and public welfare.